Inclusion body myositis coexisting with hypertrophic cardiomyopathy: An autopsy study

Neuromuscular Disorders

Volumn 22, Issue 8, 2012, Pages 747-754

  Inamori, Yukie ^a   Higuchi, Itsuro ^a   Inoue, Teruhiko ^b   Sakiyama, Yusuke ^a   Hashiguchi, Akihiro ^a   Higashi, Keiko ^a   Shiraishi, Tadafumi ^a   Okubo, Ryuichi ^a   Arimura, Kimiyoshi ^c   Mitsuyama, Yoshio ^b   Takashima, Hiroshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Daigo Hospital   (Japan)

^c Okatsu Hospital   (Japan)

Author keywords

Autopsy; Human T lymphotropic virus type 1; Hypertrophic cardiomyopathy; Inclusion body myositis; Myosin binding protein C3 gene

Indexed keywords

CREATINE KINASE; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE; PROTEIN P62; TAR DNA BINDING PROTEIN;

AGED; ARTICLE; AUTOPSY; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; ECHOCARDIOGRAPHY; GENETIC ANALYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; LOW DRUG DOSE; MALE; MISSENSE MUTATION; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS; WALKING DIFFICULTY;

AGED; AUTOPSY; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; COMORBIDITY; HUMANS; MALE; MUSCLE, SKELETAL; MUTATION; MYOCARDIUM; MYOSITIS, INCLUSION BODY;

EID: 84863878834     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.03.011     Document Type: Article

References (36)

1. Benveniste O., Hilton-Jones D. International workshop on inclusion body myositis held at the institute of myology, Paris, on 29 May 2009. Neuromuscul Disord 2010, 20:414-421.
2. Bohan A., Peter J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975, 292:403-407.
3. Bohan A., Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347.
4. Engel W.K., Askanas V. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Neurology 2006, 66:20-29.
5. Finch C.E. A perspective on sporadic inclusion-body myositis: the role of aging and inflammatory processes. Neurology 2006, 66:1-6.
6. Murphy M.P., Golde T.E. Inclusion-body myositis and Alzheimer disease: two sides of the same coin, or different currencies altogether?. Neurology 2006, 66:65-68.
7. Askanas V., Engel W.K. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 2006, 66:39-48.
8. Amato A.A., Shebert R.T. Inclusion body myositis in twins. Neurology 1998, 51:598-600.
9. Garlepp M.J., Laing B., Zilko P.J., Ollier W., Mastaglia F.L. HLA associations with inclusion body myositis. Clin Exp Immunol 1994, 98:40-45.
10. Hengstman G.J., van Engelen B.G., ter Laak H.J., Gabreels-Festen A.A. Familial inclusion body myositis with histologically confirmed sensorimotor axonal neuropathy. J Neurol 2000, 247:882-884.
11. Mastaglia F., Price P., Walters S., Fabian V., Miller J., Zilko P. Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes. Neuromuscul Disord 2006, 16:754-758.
12. Sivakumar K., Semino-Mora C., Dalakas M.C. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families. Brain 1997, 120:653-661.
13. Tateyama M., Saito N., Fujihara K. Familial inclusion body myositis: a report on two Japanese sisters. Intern Med 2003, 42:1035-1038.
14. Argov Z., Eisenberg I., Mitrani-Rosenbaum S. Genetics of inclusion body myopathies. Curr Opin Rheumatol 1998, 10:543-547.
15. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001, 104:557-567.
16. Lotz B.P., Engel A.G., Nishino H., Stevens J.C., Litchy W.J. Inclusion body myositis. Observations in 40 patients. Brain 1989, 112:727-747.
17. Higuchi I., Niiyama T., Uchida Y. Multiple episodes of thrombosis in a patient with Becker muscular dystrophy with marked expression of utrophin on the muscle cell membrane. Acta Neuropathol 1999, 98:313-316.
18. Konno T, Chang S, Seidman JG, Seidman CE. Genetics of hypertrophic cardiomyopathy. Curr Opin Cardiol 2010;25:205-9.
19. Maron B.J. The 2009 international hypertrophic cardiomyopathy summit. Am J Cardiol 2010, 105:1164-1168.
20. Millat G., Chanavat V., Crehalet H., Rousson R. Development of a high resolution melting method for the detection of genetic variations in hypertrophic cardiomyopathy. Clin Chim Acta 2010, 411:1983-1991.
21. Bahrudin U., Morisaki H., Morisaki T. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. J Mol Biol 2008, 384:896-907.
22. Oldfors A., Larsson N.G., Lindberg C., Holme E. Mitochondrial DNA deletions in inclusion body myositis. Brain 1993, 116:325-336.
23. Oldfors A., Moslemi A.R., Jonasson L., Ohlsson M., Kollberg G., Lindberg C. Mitochondrial abnormalities in inclusion-body myositis. Neurology 2006, 66:49-55.
24. Bjorkoy G., Lamark T., Johansen T. P62/SQSTM1: a missing link between protein aggregates and the autophagy machinery. Autophagy 2006, 2:138-139.
25. Nogalska A., Terracciano C., D'Agostino C., King Engel W., Askanas V. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol 2009, 118:407-413.
26. Weihl C.C., Temiz P., Miller S.E. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 2008, 79:1186-1189.
27. Ginsberg L., Malik O., Kenton A.R. Coexistent hereditary and inflammatory neuropathy. Brain 2004, 127:193-202.
28. Lerario A., Cogiamanian F., Marchesi C. Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy. BMC Musculoskelet Disord 2010, 11:157.
29. Roos P.M., Vesterberg O., Nordberg M. Inclusion body myositis in Alzheimer's disease. Acta Neurol Scand 2011, 124:215-217.
30. Kulikovskaya I., McClellan G., Flavigny J., Carrier L., Winegrad S. Effect of MyBP-C binding to actin on contractility in heart muscle. J Gen Physiol 2003, 122:761-774.
31. Niimura H., Bachinski L.L., Sangwatanaroj S. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998, 338:1248-1257.
32. Gautel M., Furst D.O., Cocco A., Schiaffino S. Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle. Circ Res 1998, 82:124-129.
33. Tajsharghi H., Leren T.P., Abdul-Hussein S. Unexpected myopathy associated with a mutation in MYBPC3 and misplacement of the cardiac myosin binding protein C. J Med Genet 2010, 47:575-577.
34. Matsuura E., Umehara F., Nose H. Inclusion body myositis associated with human T-lymphotropic virus-type I infection: eleven patients from an endemic area in Japan. J Neuropathol Exp Neurol 2008, 67:41-49.
35. Cupler E.J., Leon-Monzon M., Miller J., Semino-Mora C., Anderson T.L., Dalakas M.C. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 1996, 119:1887-1893.
36. Littleton E.T., Man W.D., Holton J.L. Human T cell leukaemia virus type I associated neuromuscular disease causing respiratory failure. J Neurol Neurosurg Psychiatry 2002, 72:650-652.